NCR3 and acute myeloid leukemia: Pre-treatment of NK cell lines with mAbs to the natural cytotoxicity receptors (NCRs), NKp30 and NKp44, can facilitate a several-fold enhancement of cytotoxicity against leukemia cell lines and primary AML blasts which express FcγRs [93].